Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 197 for “"CD133"”.
-
Functional Characterization of the Membrane Glycoprotein CD133
… of the pentaspan transmembrane glycoprotein CD133 has been used as a cell-surface marker for normal and cancer stem cells from a broad range of tissue types. Despite the utility of CD133 as a marker, little is known regarding its regulation and biological function. To study these poorly …
-
CD133-Targeted Radionuclide Therapy and Molecular Imaging
… clinical need to eradicate treatment-resistant CD133+ cancer stems within tumors, a CSC-targeted radionuclide therapy (TRT) and companion diagnostic imaging probes were developed utilizing CD133-targeting antibodies and antibody fragments. In Chapter 1, background research providing context for …
-
The role of CD133 in mouse incisor tooth epithelium
Since its discovery, CD133 has been used to identify, isolate and characterise many different stem cell types across a wide variety of tissues. Nonetheless, to date not much has been elucidated about its function in these cells. The continuously growing mouse incisor contains a large population of …
-
Biology of adult human normal and leukaemia CD133+ stem cells
Recently, CD133 has been used extensively as a marker for identification of stem cells from human normal and malignant tissues. Human normal CD 133+ stem cells are capable of multilineage in vitro and in vivo differentiation providing a novel source of stem cells for regenerative therapy, whereas, …
-
Involvement of CD133+ stem cells in the chemoresistance of glioma
… multipotency. The novel cell-membrane protein CD133 has been identified as a marker of stem-like cells in glioma. Interestingly, the CDI 33+ population of GBM has been found to be selectively resistant to radiation and chemotherapy relative to the CD133- bulk tumour mass, revealing a potential …
-
EXAMINATION OF CD133 AND CD147 AS CANCER STEM CELL MARKERS
… thus paramount. The cell surface glycoproteins CD133 and CD147 were examined as potential markers of cancer stem cells found in glioblastoma. Here we found evidence which shows that formation of neurospheres with U87MG glioblastoma cells may be driven by increased expression of CD147, correlated …
-
The Characterization and Therapeutic Targeting of CD133 in Human Glioblastoma
CD133, a pentaspan glycoprotein, has long been known to represent aggressive, stem-like populations across various human malignancies. While its expression correlates with numerous clinical outcomes including disease progression, metastasis, recurrence, and poor overall survival in numerous …
-
Targeting CD133 In Androgen Receptor Indifferent, Neuroendocrine Differentiated Aggressive Variant Prostate Cancer
… the pentaspan transmembrane glycoprotein, CD133, as a targetable antigen that is overexpressed on the surface of non-AR driven, neuroendocrine-differentiated prostate cancer. Additionally, we have developed a novel antibody, termed HA10 IgG, which was found to bind to a …
-
Signaling pathways regulating self-renewal, differentiation, and multipotency of CD133+ umbilical cord blood stem cells
… lab adapted a culture technique to grow immature CD133+ UCBSCs (CD133+ cells). Although CD133+ cells proliferate rapidly in culture, a minority self-renew and remain CD133+, while a majority differentiate and become CD133-. Therefore, new strategies to identify and grow immature UCBSCs are …
-
Development and characterization of CD133 positive cancer stem cell targeted toxins for use in carcinoma therapy
… single most urgent problem in carcinoma therapy. CD133 is a cell surface receptor that has been identified as a CSC marker in breast, brain, colon, pancreatic, and recently in Head and Neck (HN) carcinoma. Our laboratory bioengineered a targeted toxin called dCD133KDEL consisting of the scFv …
-
THE ROLE OF CD133 IN THE IDENTIFICATION AND MAINTENANCE OF CANCER STEM CELLS DERIVED FROM HUMAN GLIOBLASTOMA
… patients’ survival. The role of the cell surface CD133 as a cancer stem cell marker in brain tumors has been widely investigated, since it identifies cells within glioblastomas able to initiate neurosphere growth and form heterogeneous tumors when transplanted in immune-compromised mice. However, …
-
The use of granulocyte-colony stimulating factor and an intracoronary CD133+ cell infusion in patients with chronic refractory ischaemic heart disease.
… of an intracoronary infusion of G-CSF mobilised CD133+ cells. The study involved initial baseline cardiac ischaemia assessment (symptom based questionnaire, exercise stress test (EST), nuclear Sestamibi (MIBI) and dobutamine stress echocardiographic (DSE) imaging). Stable 'no-option' IHD patients …
-
Investigation of Cancer Stem Cells (CSCs)-derived exosomes and their influence on the tumor microenvironment
… and CD81, LCSC-derived exosomes are enriched in CD133 protein. Immunoprecipitation (IP) experiments revealed that by immunoprecipitating the culture SN of CD133 expressing cells with an antibody against CD133 protein, typical exosomal markers, such as Tsg101 and Rab5b, are contained in the …
-
Vergleich eines Stammzellmarkerprofils in einem Panel ausgewählter Kolontumorzelllinien in vitro und den korrespondierenden Xenografts in vivo
… Es wurden die Oberflächenproteine CD133, CD24, CD44, CDCP1 und CXCR4 ausgewählt, deren Expression zunächst bei einer Auswahl von 15 verschiedenen Kolontumorzelllinien mittels Durchflusszytometrie bestimmt werden sollte. Tumorzelllinien zeigen ähnliche funktionelle Hierarchien wie …
-
Molecular Mechanisms of Stemness and Invasion in Pancreatic Cancer
… These studies focus to examine the role of CD133 positive cancer stem cells in stemness and metastasis within pancreatic cancer. We demonstrated that CD133 positive pancreatic cancer cells, from human pancreatic cancer cell lines and a spontaneous murine model of pancreatic cancer, are …
-
Small cell lung cancer and cancer stem cell-like cells
… cell lines contain a subset of cells expressing CD133, a known CSC marker. CD133+ SCLC sub-population maintained their stem cell-like phenotype over a prolonged period of culture, differentiated in appropriate conditions and expressed the embryonic stem cell marker Oct-4 indicating their …
Page 1 of 10